Pharmaceutical & Biologics advances in pharmaceuticals and biologics have improved the health of millions of individuals, decreased the prevalence of preventable diseases, and permitted chronic diseases to kept over an extended time period. These advances have actually extended life span for millions of people, especially those with persistent diseases and some cancers.Nevertheless, the intensifying costs of pharmaceuticals and biologics places these interventions and treatments out of reach for far too numerous individuals. Policies need to be established that enable purchasers of healthcare, including Medicare, to work out the costs of prescription drugs. Additionally, there must be greater versatility in the style of formularies that allow for increased usage of generic and bio-similar products.